214 related articles for article (PubMed ID: 21183492)
1. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity.
Torrisi JM; Schwartz LH; Gollub MJ; Ginsberg MS; Bosl GJ; Hricak H
Radiology; 2011 Jan; 258(1):41-56. PubMed ID: 21183492
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of medication-induced complications in the abdomen: role of cross-sectional imaging.
Shanbhogue AK; Virmani V; Vikram R; Prasad SR; Shanbhogue DK; Nagar A; Fasih N
AJR Am J Roentgenol; 2011 Aug; 197(2):W286-94. PubMed ID: 21785055
[TBL] [Abstract][Full Text] [Related]
3. New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know.
Souza FF; Smith A; Araujo C; Jagannathan J; Johnston C; O'Regan K; Shinagare A; Ramaiya N
Cancer Imaging; 2014 Jul; 14(1):26. PubMed ID: 25608887
[TBL] [Abstract][Full Text] [Related]
4. Biliary and pancreatic complications of molecular targeted therapies in cancer imaging.
Alessandrino F; Krajewski KM; Tirumani SH; Braschi-Amirfarzan M; Jagannathan JP; Ramaiya NH; Di Salvo DN
Abdom Radiol (NY); 2017 Jun; 42(6):1721-1733. PubMed ID: 28160038
[TBL] [Abstract][Full Text] [Related]
5. Abdominal and pelvic complications of nonoperative oncologic therapy.
Viswanathan C; Truong MT; Sagebiel TL; Bronstein Y; Vikram R; Patnana M; Silverman PM; Bhosale PR
Radiographics; 2014; 34(4):941-61. PubMed ID: 25019433
[TBL] [Abstract][Full Text] [Related]
6. Ocular toxicity of targeted therapies.
Renouf DJ; Velazquez-Martin JP; Simpson R; Siu LL; Bedard PL
J Clin Oncol; 2012 Sep; 30(26):3277-86. PubMed ID: 22649132
[TBL] [Abstract][Full Text] [Related]
7. Management of pulmonary toxicity associated with targeted anticancer therapies.
Teuwen LA; Van den Mooter T; Dirix L
Expert Opin Drug Metab Toxicol; 2015; 11(11):1695-707. PubMed ID: 26293379
[TBL] [Abstract][Full Text] [Related]
8. Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?
Rohatgi S; Jagannathan JP; Rosenthal MH; Kim KW; Ramaiya NH; Krajewski KM
AJR Am J Roentgenol; 2014 Dec; 203(6):1353-62. PubMed ID: 25415715
[TBL] [Abstract][Full Text] [Related]
9. Pathologies of the lower abdomen and pelvis: PET/CT reduces interpretation errors due to urinary contamination.
Harder JN; Hany TF; von Schulthess GK; Goerres GW
Clin Imaging; 2008; 32(1):16-21. PubMed ID: 18164389
[TBL] [Abstract][Full Text] [Related]
10. Ocular adverse events of molecularly targeted agents approved in solid tumours: a systematic review.
Huillard O; Bakalian S; Levy C; Desjardins L; Lumbroso-Le Rouic L; Pop S; Sablin MP; Le Tourneau C
Eur J Cancer; 2014 Feb; 50(3):638-48. PubMed ID: 24256808
[TBL] [Abstract][Full Text] [Related]
11. Imaging of hepatic toxicity of systemic therapy in a tertiary cancer centre: chemotherapy, haematopoietic stem cell transplantation, molecular targeted therapies, and immune checkpoint inhibitors.
Alessandrino F; Tirumani SH; Krajewski KM; Shinagare AB; Jagannathan JP; Ramaiya NH; Di Salvo DN
Clin Radiol; 2017 Jul; 72(7):521-533. PubMed ID: 28476244
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal toxicities from targeted therapies: measurement, duration and impact.
Bossi P; Lucchesi M; Antonuzzo A
Curr Opin Support Palliat Care; 2015 Jun; 9(2):163-7. PubMed ID: 25872123
[TBL] [Abstract][Full Text] [Related]
13. [Management of adverse effects of targeted therapy toxicities in oncology].
Coquan E; Henri P; de Raucourt S; Lireux B; Lamy E; Delcambre C; Sevin E; Dutriaux C; Bouhier-Leporrier K; Gervais R; Joly F
Rev Prat; 2012 Jan; 62(1):17-25. PubMed ID: 22335060
[TBL] [Abstract][Full Text] [Related]
14. Heart failure caused by molecularly targeted therapies for cancer.
Jarkowski A; Glode AE; Spangenthal EJ; Wong MK
Pharmacotherapy; 2011 Jan; 31(1):62-75. PubMed ID: 21182360
[TBL] [Abstract][Full Text] [Related]
15. Manifestations of drug toxicity.
Mettler FA
Curr Probl Diagn Radiol; 1979; 8(4):1-55. PubMed ID: 387339
[No Abstract] [Full Text] [Related]
16. Pulmonary toxicity related to systemic treatment of nonsmall cell lung cancer.
De Sanctis A; Taillade L; Vignot S; Novello S; Conforti R; Spano JP; Scagliotti GV; Khayat D
Cancer; 2011 Jul; 117(14):3069-80. PubMed ID: 21283982
[TBL] [Abstract][Full Text] [Related]
17. Understanding Toxicities of Targeted Agents: Implications for Anti-tumor Activity and Management.
Liu S; Kurzrock R
Semin Oncol; 2015 Dec; 42(6):863-75. PubMed ID: 26615131
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal toxicity of chemotherapeutic agents.
Mitchell EP
Semin Oncol; 2006 Feb; 33(1):106-20. PubMed ID: 16473649
[TBL] [Abstract][Full Text] [Related]
19. Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities.
Krajewski KM; Braschi-Amirfarzan M; DiPiro PJ; Jagannathan JP; Shinagare AB
Korean J Radiol; 2017; 18(1):28-41. PubMed ID: 28096716
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
